Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...

A slowdown of the digestive tract (gastroparesis) can be a serious side effect, though. Researchers who analyzed the health records of 16 million people revealed that pancreatitis and bowel ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart ...

Law enforcement officers searched a home that was supplying weight loss clinics in two different counties with the drugs.

Drugs used to treat diabetes and obesity, or GLP-1 (Glucagon-like peptide-1), will be a significant growth driver for ...

Microsoft products and services—including images, text, and software downloads (the "content")—are owned either by Microsoft Corporation or by third parties who have granted Microsoft permission to ...

Buses are an easy and affordable way to travel around London, with 95% of Londoners living within 400 meters of a bus stop and our Hopper fare giving you unlimited journeys within one hour of touching ...